Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FVS Injection for Rhizarthrosis
NCT05708430Phase 2Recruiting
- Sponsor
- Rouen University Hospital
- Start
- Feb 2024
- Primary completion
- Dec 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous adipose-derived stromal vascular fraction in Rhizarthrosis, sponsored by Rouen University Hospital. Started Feb 2024; status: recruiting.
02
Drugs
autologous adipose-derived stromal vascular fraction
03
Conditions
Rhizarthrosis
Beyond the preview
Go deeper on NCT05708430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05708430.